Antimycotics TRIZ Cases

Modified peptide sequences penetrate protective biofilms while preserving eukaryotic cell integrity through optimized charge distribution.

A hydrogel formulation containing urea and fumaric acid delivers targeted keratolytic activity to infected nail tissue.

Silica gel chromatography separates caspofungin cyclopeptides from unstable impurities, reducing process complexity and improving yield.

Modular hydrazide compounds overcome multidrug resistance by targeting bacterial, fungal, and viral infections through optimized structural parameters.

Topical fungal iron acquisition inhibitors sequester iron to starve pathogens, reducing corneal transplant needs in keratitis.

Heat-killed fbp1Δ deletion mutant fungal cells generate protective immunity without the toxicity of traditional antifungal medications.

Sequential solvent extraction segments impurities from Paliurus ramosissimus, resolving the trade-off between high purity and processing time.

Chitosan polysaccharide conjugates overcome variable efficacy of existing vaccines by targeting conserved cell wall epitopes for broad-spectrum protection.

Engineered HeSPs sequester heme from biological environments, lowering mitochondrial levels and suppressing tumor growth in non-small cell lung cancer.

Modified echinocandin structure extends half-life while reducing gastrointestinal side effects.

Anionic sequestering compounds bind cationic antimicrobial peptides, reducing skin irritation and inflammation while maintaining treatment efficacy for rosacea.

A mucoadhesive vaginal tablet compresses Lactobacillus with an excipient to ensure prolonged drug release and mucosal adhesion.

Adding aluminum sulfate to diaphragm electrolysis anolytes prevents decomposition of oxidizing compounds, enabling broad biocidal applications.

Plant-mediated reduction eliminates toxic by-products from chemical synthesis while maintaining controlled nanoparticle size for eumycetoma treatment.

Heat-killed fbp1Δ mutant fungal cells stimulate robust Th1 and Th17 immune responses to confer protective immunity.

Micafungin sodium solvate forms column-like crystals via controlled solvent systems, resolving poor stability and difficult filtration of amorphous forms.

Antibiotics often fail to clear persistent biofilms, causing chronic inflammation. This enzyme mixture extracts the matrix while preserving tissue integrity.

A transdermal preparation combines compound A with absorption enhancers to improve skin permeability.

Evaluating luliconazole crystals by surface free energy and polar component ratio suppresses isomer formation under high humidity.

Modified peptide YY peptides target Candida albicans to inhibit fungal virulence and biofilm formation.

Segmentation of peptide fractions resolves the trade-off between solubility and bioavailability, treating intestinal inflammation.

Microwave energy modulates the host immune response to disrupt fungal compounds, resolving tissue damage risks from traditional thermal treatments.

Segmenting the antigen and optimizing codons resolves expression failures, enabling reliable production of protective immunogens.

Pre-filling the mold cavity prevents cement overflow during core insertion, eliminating high-pressure injection requirements.

Topical Gynura procumbens oil extract overcomes nail plate barriers to treat onychomycosis without systemic side effects.

Glycerol stabilizes urea in topical nail compositions to prevent chemical degradation, enabling effective antifungal treatment with improved patient compliance.

A lysozyme and chitosan complex suppresses fungal proliferation through chemical bonding.

Monoclonal antibodies targeting Pra1 and Tef1 inhibit complement activation, reducing clinical symptoms and prolonging survival in invasive fungal infections.

Humanized antibodies bind beta-1,3 glucans on fungal cell walls to promote innate immunity and inhibit pathogen growth.

A subungual delivery device deposits antifungal agents directly into the nail bed using a biodegradable polymer matrix for controlled release.

Modifying R1, R2, and X substituents on the inhibitor structure enhances binding affinity across multiple HCV genotypes while reducing toxicity risks.

Genetically modified tumor infiltrating lymphocytes with CISH gene disruption enhance anti-tumor function.

A monoclonal antibody vaccine targets conserved fungal epitopes to induce protective immune responses against invasive infections.

Occidiofungin cyclic glycopeptide targets cell envelope integrity to overcome antifungal resistance and toxicity trade-offs.

A malleable paste combines demineralized bone matrix with a polysaccharide liquid carrier to form a workable medical composition.

Combining miconazole with domiphen bromide achieves a greater than three log unit reduction in Candida biofilm colony forming units.

An automated nebulizing device delivers calibrated micronized nutritional suspensions to honeybee colonies.

Detecting candidalysin-secreting C. albicans strains enables precise IL-1 pathway inhibition.

Inhibiting Cdr1p transporter expression restores azole susceptibility in resistant Candida strains without mammalian cytotoxicity.

A hydrogel formulation with 45 to 60 wt% water delivers active ingredients into the nail.

Stabilized efinaconazole composition maintains color stability using butylated hydroxytoluene and ethylenediaminetetraacetic acid salts.

Cyclic depsipeptides overcome azole resistance by introducing new antifungal mechanisms to treat drug-resistant infections.

Merging lactoferrin metal chelation with honey antimicrobial factors overcomes weak individual inhibition while reducing side effects from high doses.

A crystalline powder of Micafungin forms through a three-phase solvent system to yield column-like morphology.

Saccharomyces boulardii supernatant protects respiratory cells from H1N1 cytopathic effects while avoiding side effects of conventional antivirals.

A defined T cell product comprising specific populations reactive with fungal, viral, or tumor antigens.

Plant defensins penetrate keratin layers to deliver targeted fungicidal activity, resolving poor permeation that limits conventional onychomycosis treatments.